Fully percutaneous vs. surgical transfemoral TAVR: similar major vascular complications rate and shorter hospital stay.

Original title: Factors associated with vascular complications in patients undergoing balloon-expandable transfemoral transcatheter aortic valve replacement via open versus percutaneous approaches. Reference: Kadakia MB et al. Circ Cardiovasc Interv. 2014; Epub ahead of print.

 

This retrospective study included 331 patients undergoing transfemoral TAVR in one center between 2007 and 2013. 64% of the population were treated with the fully percutaneous approach and the rest via the open surgical approach. Only the Edwards valve was employed (Sapien o Sapien XT).

At baseline, patients in the open surgical group presented major heart disease, previous infarction, chronic renal failure, worse functional class and higher STS score (11.1 vs 9.1; p=0.007). Those treated with fully percutaneous approach presented shorter length of stay (7.7 vs 9.9 days; p=0.003) and fewer vascular complications at 30 days (11% vs 20%: p=0.03).

The most common complications in both groups were iliofemoral perforation and iliofemoral dissection. There was no difference in all-cause in-hospital mortality between the groups.

After propensity score matching, on account of the different baseline characteristics, each group had 112 patients. The difference in major vascular complications disappeared (13% vs 15%; p=0.7) but the advantage of the fully percutaneous approach as regards hospital stay length remained (7.9 ± 5.5 days vs 10.0 ± 10.1; p=0.04).

The multivariable analysis showed 2 predictors of overall vascular complications: female sex (OR 2.2; IC 95% 1.1 a 4.3) and sheath oversizing (per 1 mm increase in the difference between sheath outer diameter and minimal artery diameter; OR 1.4; IC 95% 1.1 to 1.8).

Conclusion

Fully percutaneous TAVR was associated with a similar vascular complications risk and a significant shorter hospital stay compared to open surgical TAVR. Sheath oversizing (with respect to artery diameter), and female sex were associated to vascular complications, despite the approach.

Editorial Comment

Technological advances will continue to reduce sheath size, which in turn will reduce vascular complications. However, in the individual patient, outcomes will depend on careful planning, since sheath oversizing is the strongest predictor of vascular complications. 

A shorter hospital stay and a similar vascular complications rate makes the percutaneous approach the ideal technique; however, closure device cost vs. hospital cost should always be pondered on account of the different contexts in different countries. 

SOLACI.ORG

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....